CHURCHILL MANAGEMENT Corp Sells 237 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

CHURCHILL MANAGEMENT Corp trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 21,809 shares of the healthcare conglomerate’s stock after selling 237 shares during the quarter. CHURCHILL MANAGEMENT Corp’s holdings in UnitedHealth Group were worth $11,422,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Financial Management Professionals Inc. lifted its holdings in shares of UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock worth $1,165,000 after purchasing an additional 17 shares in the last quarter. Richwood Investment Advisors LLC raised its holdings in UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after buying an additional 20 shares during the last quarter. Global Wealth Strategies & Associates grew its holdings in shares of UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after buying an additional 20 shares during the last quarter. Kolinsky Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 1.0% in the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate’s stock worth $1,080,000 after acquiring an additional 21 shares during the last quarter. Finally, Retirement Planning Group LLC boosted its stake in UnitedHealth Group by 5.1% during the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after purchasing an additional 21 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.9%

Shares of NYSE UNH opened at $311.89 on Tuesday. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The business’s fifty day moving average price is $333.94 and its 200-day moving average price is $452.07. The stock has a market capitalization of $282.93 billion, a PE ratio of 13.06, a P/E/G ratio of 1.46 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter in the previous year, the business earned $6.91 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.83%. UnitedHealth Group’s dividend payout ratio is 37.02%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on UNH. Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. TD Securities restated a “hold” rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Truist Financial reiterated a “buy” rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. Finally, Robert W. Baird lowered shares of UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price objective for the company. in a research note on Wednesday, June 11th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $415.57.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director directly owned 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kristen Gil purchased 3,700 shares of the firm’s stock in a transaction dated Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director owned 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.